LivaNova PLC (LIVN)
NASDAQ: LIVN · IEX Real-Time Price · USD
53.61
+0.16 (0.30%)
Jul 26, 2024, 4:00 PM EDT - Market closed
LivaNova Market Cap
LivaNova has a market cap or net worth of $2.90 billion as of July 26, 2024. Its market cap has increased by 1.70% in one year.
Market Cap
2.90B
Enterprise Value
2.96B
1-Year Change
1.70%
Ranking
Category
Stock Price
$53.61
Market Cap Chart
Since October 19, 2015, LivaNova's market cap has decreased from $3.42B to $2.90B, a decrease of -15.00%. That is a compound annual growth rate of -1.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 2.89B | 3.84% |
| Dec 29, 2023 | 2.79B | -6.24% |
| Dec 30, 2022 | 2.97B | -36.12% |
| Dec 31, 2021 | 4.65B | 44.63% |
| Dec 31, 2020 | 3.22B | -11.87% |
| Dec 31, 2019 | 3.65B | -18.02% |
| Dec 31, 2018 | 4.45B | 15.57% |
| Dec 29, 2017 | 3.85B | 75.67% |
| Dec 30, 2016 | 2.19B | -24.35% |
| Dec 31, 2015 | 2.90B | -15.10% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ICU Medical | 3.08B |
| Rhythm Pharmaceuticals | 3.04B |
| ACADIA Pharmaceuticals | 3.02B |
| Amicus Therapeutics | 3.01B |
| Apogee Therapeutics | 2.99B |
| MoonLake Immunotherapeutics | 2.90B |
| agilon health | 2.90B |
| Tandem Diabetes Care | 2.86B |